Nep123.com
High-risk bladder patients can benefit from immunotherapy

High-risk bladder patients can benefit from immunotherapy

High-risk bladder patients can benefit from immunotherapy

 According to clinical trial results, immunotherapy after surgery increased bladder cancer patients’ chance of staying cancer-free compared to patients who received a placebo.

In February, these results were shared in a late-breaking oral presentation at the American Society of Clinical Oncology (ASCO) 2023 Genitourinary Cancers Symposium.

Matthew Galsky, MD, Co-Director of the Center of…


Read full story at NepalNews.com


Nepalnews.com

Add comment

Follow us

Don't be shy, get in touch. We love meeting interesting people and making new friends.

Most popular